瑞典肥胖受试者研究中减重手术或常规治疗后女性特异性癌症的长期发病率
该前瞻性匹配的瑞典肥胖受试者(SOS)研究纳入1420例接受减重手术的女性和1447例同期匹配接受常规肥胖治疗的对照,中位随访18.1年。减重手术与总体癌症风险降低相关(HR=0.71),女性特异性癌症风险亦降低(HR=0.68),子宫内膜癌风险降低(HR=0.56),基线血清胰岛素水平与手术获益存在交互作用。
要点
- 减重手术与女性总体癌症风险降低相关(HR=0.71,95%CI 0.59-0.85)。
- 减重手术与女性特异性癌症风险降低相关(HR=0.68,95%CI 0.52-0.88)。
- 减重手术与子宫内膜癌风险降低相关(HR=0.56,95%CI 0.35-0.89)。
核心结论
- 在这项长期研究中,减重手术与女性特异性癌症风险降低相关,尤其在基线存在高胰岛素血症的女性中。
研究设计与样本
- 前瞻性匹配的瑞典肥胖受试者(SOS)研究,纳入1420例接受减重手术的女性和1447例同期匹配接受常规肥胖治疗的对照。
- 年龄37-60岁,BMI≥38kg/m2,中位随访18.1年(四分位距14.8-20.9年,最长26年)。
- 癌症事件信息来自瑞典国家癌症登记处,研究注册号ClinicalTrials.gov NCT01479452。
主要发现
- 减重手术与总体癌症风险降低相关(HR=0.71;95%CI 0.59-0.85;p<0.001)。
- 女性特异性癌症发病率在手术组低于对照组(HR=0.68;95%CI 0.52-0.88;p=0.004)。
- 手术对女性特异性癌症的治疗获益与基线血清胰岛素显著相关(交互作用p=0.022),中等或高胰岛素水平患者相对治疗获益更大。
- 减重手术与子宫内膜癌风险降低相关(HR=0.56;95%CI 0.35-0.89;p=0.014)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the long-term effects of bariatric surgery on female-specific cancer in women with obesity. METHODS: The prospective, matched Swedish Obese Subjects (SOS) study was designed to examine outcomes after bariatric surgery. This study includes 1420 women from the SOS cohort that underwent bariatric surgery and 1447 contemporaneously matched controls who received conventional obesity treatment. Age was 37-60years and BMI was ≥38kg/m2. Information on cancer events was obtained from the Swedish National Cancer Registry. Median follow-up time was 18.1years (interquartile range 14.8-20.9years, maximum 26years). This study is registered with ClinicalTrials.gov, NCT01479452. RESULTS: Bariatric surgery was associated with reduced risk of overall cancer (hazard ratio=0.71; 95% CI 0.59-0.85; p<0.001). About half of the observed cancers were female-specific, and the incidence of these were lower in the surgery group compared with the control group (hazard ratio=0.68; 95% CI 0.52-0·88; p=0.004). The surgical treatment benefit with respect to female-specific cancer was significantly associated with baseline serum insulin (interaction p value=0.022), with greater relative treatment benefit in patients with medium or high insulin levels. Separate analyses of different types of female-specific cancers showed that bariatric surgery was associated with reduced risk of endometrial cancer (hazard ratio=0.56: 95% CI 0.35-0.89; p=0.014). CONCLUSIONS: In this long-term study, bariatric surgery was associated with reduced risk of female-specific cancer, especially in women with hyperinsulinemia at baseline. FUNDING: This project was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK105948 (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health), the Swedish Research Council K2013-99X-22279-01, K2013-54X-11285-19, Sahlgrenska University Hospital ALF research grant and Swedish Diabetes Foundation.
引用
- Anveden Å, Taube M, Peltonen M, et al. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol. 2017. PMID: 28259424. doi:10.1016/j.ygyno.2017.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。